MODERNATX Gains $3.3 Million Contract Modification
Copyright © Targeted News Service 2021
2021-06-25
WASHINGTON, June 25 -- The U.S. Army Contracting Command issued the following high-value contract information through the Pentagon on June 21, 2021:
MODERNATX, Cambridge, Massachusetts, was awarded a $3,300,000,000 modification to a contract (W911QY-20-C-0100) for 200 million filled drug production doses of SARS-CoV-2 mRNA-1273 Moderna vaccine.
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded June 15, 2021) [D . . .
MODERNATX, Cambridge, Massachusetts, was awarded a $3,300,000,000 modification to a contract (W911QY-20-C-0100) for 200 million filled drug production doses of SARS-CoV-2 mRNA-1273 Moderna vaccine.
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded June 15, 2021) [D . . .
